Phibro Animal Health (NASDAQ:PAHC) Reaches New 52-Week High – Time to Buy?

Phibro Animal Health Co. (NASDAQ:PAHC)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $24.56 and last traded at $24.45, with a volume of 110351 shares changing hands. The stock had previously closed at $24.15.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock. Bank of America boosted their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. Three analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus price target of $15.00.

Phibro Animal Health Stock Up 2.9 %

The firm has a 50-day simple moving average of $20.70 and a two-hundred day simple moving average of $18.09. The stock has a market cap of $1.01 billion, a P/E ratio of 77.91, a PEG ratio of 0.55 and a beta of 0.52. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. The business had revenue of $273.16 million during the quarter, compared to analysts’ expectations of $262.44 million. Equities research analysts expect that Phibro Animal Health Co. will post 1.55 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.93%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 150.00%.

Insider Activity at Phibro Animal Health

In other news, Director E Thomas Corcoran acquired 5,000 shares of Phibro Animal Health stock in a transaction on Wednesday, September 4th. The shares were purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the purchase, the director now directly owns 25,000 shares of the company’s stock, valued at approximately $500,500. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 50.06% of the stock is owned by insiders.

Hedge Funds Weigh In On Phibro Animal Health

Several hedge funds and other institutional investors have recently modified their holdings of PAHC. Sofinnova Investments Inc. acquired a new stake in shares of Phibro Animal Health in the 2nd quarter valued at approximately $3,975,000. American Century Companies Inc. grew its position in Phibro Animal Health by 119.6% during the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after acquiring an additional 189,068 shares during the last quarter. Acadian Asset Management LLC increased its holdings in Phibro Animal Health by 32.8% in the 1st quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock worth $8,726,000 after purchasing an additional 166,776 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Phibro Animal Health by 165.9% during the fourth quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after purchasing an additional 102,793 shares in the last quarter. Finally, Dana Investment Advisors Inc. grew its holdings in shares of Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after purchasing an additional 75,546 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.